Advent Life Sciences LLP
London, United Kingdom WWW.ADVENTLS.COM Exempt reporting adviser
Advent Life Sciences LLP reports 7 venture funds on Form ADV among 7 private funds, with $830M in gross private fund assets.
The numbers
| Began raising | Raised |
|---|---|
| 2018 | $25M |
| 2024 | $9.8M |
Updates from Advent Life Sciences LLP
Funds on Form D
Venture funds whose Form D filings carry this adviser’s name, matched by name. Amounts are what each fund last reported to the SEC.
| Fund | Began raising | Target | Raised | Investors | Latest filing |
|---|---|---|---|---|---|
| Advent Life Sciences Growth Fund LP | 2024 | Not stated | $9.8M | 1 | November 7, 2025 |
| Advent Life Sciences Fund III LP | 2018 | $281M | $25M | 3 | December 6, 2019 |
LPs on the record
No foundation or public plan in the reports we read names this adviser’s funds yet. Find LPs that back firms like it: name a few peers and Hottub ranks the LPs that hold their funds.
Registration
- Legal name
- Advent Life Sciences LLP
- Status
- Exempt reporting adviser since April 9, 2015
- CRD number
- 173031
Full Form ADV on the SEC’s Investment Adviser Public Disclosure site
About this data
Registered and exempt reporting advisers that report managing at least one venture capital fund on Form ADV, with the number of private funds and their gross assets as each adviser reports them. Advisers whose business name reads as an individual's are left out. From the roster published for September 2026. Source. Benchmarks for funds like these are in Raise benchmarks.
Share this page
For a post, a deck, or a note to your partners: image (PNG) · vector (SVG).
